According to a comprehensive article by journalist Ronan Farrow in The New Yorker, it is alleged that Elon Musk’s increased use of the drug ketamine may be the reason behind his erratic decision-making at X and his other companies. Farrow’s year-long report, citing “associates,” suggests that Musk’s use of the drug has intensified in recent years and that it, along with his isolation and deteriorating relationship with the media, could contribute to his tendency to make chaotic and impulsive statements and decisions.
In recent months, Musk has faced criticism for a series of eyebrow-raising moves, such as his decision to acquire struggling Twitter for an inflated $44 billion price tag and his more recent rebranding of the company to “X,” abandoning its iconic blue bird logo. The New Yorker article references commentary from a leading ketamine researcher, Amit Anand, who confirms that the use of the drug can lead to increased erratic behavior. Anand explains that ketamine can cause disinhibition, similar to the effects of alcohol, where individuals may say or do things they wouldn’t otherwise. At higher doses, ketamine can induce dissociation, making users feel detached from their body and surroundings. Anand also notes that ketamine can make individuals feel grandiose and as if they possess special powers or talents.
Furthermore, the report highlights that the impact of ketamine use on behavior is dependent on the type of work one is engaged in. Anand explains that someone in a low-risk profession like a librarian may experience fewer consequences, whereas for a pilot, the risks could be significant. The article includes a quote from a close colleague of Musk, who describes Musk’s life as immensely stressful due to his unwavering dedication to his companies. The colleague attests to Musk’s relentless work habits, which involve answering emails both late at night and early in the morning. According to the article, this level of obsession and sacrifice is unparalleled to most people.
When contacted for comment, X replied with an automated message stating that they would respond shortly. In another report by The Wall Street Journal earlier this year, it was mentioned that Musk “takes ketamine,” along with other prominent figures in Silicon Valley who have started experimenting with micro doses of psychedelics. Musk seemingly responded to this report via Twitter, suggesting that ketamine could be a viable alternative to SSRIs as an antidepressant.
It is worth noting that Musk’s behavior has previously attracted attention. In 2019, he faced a Pentagon review of his security clearance after being filmed smoking marijuana during an appearance on “The Joe Rogan Experience” podcast. Additionally, in 2018, The New York Times reported concerns from members of Tesla’s board regarding Musk’s use of the sleep drug Ambien.
Overall, it is evident that there are claims regarding Elon Musk’s alleged increased use of ketamine and its potential impact on his decision-making and behavior. These claims are based on anonymous insider sources and expert opinions.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
